COVID-19 and Cancer Patients: What You Should Know
The Facebook live event, COVID-19 and Cancer Patients: What You Should Know, was hosted by Massive Bio on January 13, 2021. The live event featured interviews about COVID-19 and its effect on cancer patients from Massive Bio medical experts. Guests included Massive Bio’s Co-founder and Chief Medical Advisor, Dr. Arturo Loaiza-Bonilla, MD; Chief Nursing Officer, …
Non-Hodgkin’s Lymphoma (Follicular Lymphoma)
Free Matching to Cancer Clinical Trials Your match report contains a detailed list of cervical cancer clinical trials that you may be eligible to enroll in to receive unique and nonconventional treatment. Standard treatment is not the only option. A patient advocate will review your report with you to answer any questions or concerns you may …
Non-Hodgkin’s Lymphoma
The American Cancer Society estimates about 77,420 people will be diagnosed with Non-Hodgkin’s Lymphoma (NHL) in 2020. Non-Hodgkin’s Lymphoma is a type of cancer that first begins in the lymphatic system, which is the system in the body that fights against disease and infections. It is the most common type of lymphoma. In NHL, abnormal …